Snapshot · Medtronic plc (MDT)

Data as of 2026-10-18T09:57:59.530Z

Fundamentals check

Market cap

$121.2B

P/E (TTM)

23.2

Gross margin

66.7%

Net margin

13.9%

ROE

10.6%

R&D / revenue

7.8%

Dividend yield

3.0%

FCF yield

5.1%

Latest dividend: $0.72/share (ex-date 2026-09-25, quarterly)

Summary

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

How it makes money

Revenue mix, latest fiscal year

• Cardiac and Vascular Group38.6%
• Neuroscience Group28.4%
• Medical Surgical24.4%
• Diabetes Group8.6%

Recent Events

• 2026-10-15T10:00:00.000Zpositive

  Medtronic Completes Separation of MiniMed Group, Inc.

  恰逢 MiniMed 从 Medtronic 分拆完成，可能与 MDT 的独立进程相关，市场对分拆结果的第一日反应或有助于情绪改善。

  Source: prnewswire.com

• 2026-10-14T08:00:00.000Zneutral

  Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer

  最终结果公布，可能与 MiniMed 换股交易完成有关，恰逢市场对分拆后股本结构的再评估，仍存在不确定性。

  Source: prnewswire.com

• 2026-10-12T08:45:00.000Zneutral

  Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer

  初步结果显示换股要约超额认购，可能与分拆相关，但不构成因果断言，市场反应尚不确定。

  Source: prnewswire.com

• 2026-10-12T00:00:00.000Zpositive

  Price move: MDT rose 3.9%

  MDT 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-10-07T17:31:00.000Zneutral

  Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.

  关于最终换股比率的公告，可能与分拆后股权安排相关，市场反应存在不确定性，需观察后续影响。

  Source: prnewswire.com

• 2026-09-14T00:00:00.000Zpositive

  Price move: MDT rose 3.1%

  MDT 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-28T00:00:00.000Zpositive

  Price move: MDT rose 3.2%

  MDT 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $102.09 from 11 analysts (last quarter)

Insider & Congress activity

Open-market trades only; grants and exercises excluded

• 2026-10-15SellMartha Geoffrey(director, officer: Chairman and CEO)50,000 shares
• 2026-10-15SellMarinaro Michael(officer: EVP, Pres MedSurg and Americas)10,420 shares
• 2026-09-16SellKIIL HARRY SKIP(officer: EVP & President Cardiovascular)1,483 shares

Earnings Calendar

2026-11-17

EPS estimate: 1.34

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。